Home

STERIS plc (Ireland) Ordinary Shares (STE)

225.81
+3.09 (1.39%)

Steris Corp is a leading provider of infection prevention and sterilization solutions for healthcare and industrial applications

The company offers a broad range of products and services designed to enhance patient safety, improve operational efficiency, and maintain compliance within hospitals and other medical environments. Steris is known for its advanced technologies in sterilization equipment, surgical instruments, and cleaning products, as well as its commitment to infection control protocols. Additionally, Steris supports healthcare facilities with training and advisory services to help optimize their sterilization processes and ensure the highest standards of hygiene.

SummaryNewsPress ReleasesChartHistoricalFAQ
Solventum (SOLV) Reports Q4: Everything You Need To Know Ahead Of Earnings
Healthcare solutions provider Solventum (NYSESOLV) will be reporting results tomorrow afternoon. Here’s what to look for.
Via StockStory · February 26, 2025
1 Healthcare Stock Primed for Growth and 2 to Avoid
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and 2024. This has weighed on the returns lately as the industry has pulled back by 1.7% over the past six months. This performance is a noticeable divergence from the S&P 500’s 9% return.
Via StockStory · February 17, 2025
1 Healthcare Stock Primed for Growth and 2 to Snub
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 1.7%. This drop is a stark contrast from the S&P 500’s 9% gain.
Via StockStory · February 17, 2025
Forecasting The Future: 4 Analyst Projections For Sterisbenzinga.com
Via Benzinga · February 6, 2025
Earnings Scheduled For February 5, 2025benzinga.com
Via Benzinga · February 5, 2025
Steris Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)benzinga.com
Via Benzinga · November 18, 2024
Earnings Outlook For Sterisbenzinga.com
Via Benzinga · November 5, 2024
Cracking The Code: Understanding Analyst Reviews For Sterisbenzinga.com
Via Benzinga · October 24, 2024
STERIS (NYSE:STE) Reports Sales Below Analyst Estimates In Q4 Earnings
Medical equipment and services company Steris (NYSESTE). fell short of the market’s revenue expectations in Q4 CY2024, but sales rose 5.6% year on year to $1.37 billion. Its non-GAAP profit of $2.32 per share was in line with analysts’ consensus estimates.
Via StockStory · February 5, 2025
This Tesla Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursdaybenzinga.com
Via Benzinga · October 24, 2024
What's Going On With Constellation Brands Stock Today?benzinga.com
Constellation Brands' stock rises despite revising FY25 EPS and sales forecasts and anticipating a significant non-cash goodwill impairment.
Via Benzinga · September 3, 2024
Where Steris Stands With Analystsbenzinga.com
Via Benzinga · September 3, 2024
Evaluating Steris: Insights From 4 Financial Analystsbenzinga.com
Via Benzinga · August 7, 2024
STE Stock Earnings: Steris Beats EPS, Beats Revenue for Q1 2025investorplace.com
STE stock results show that Steris beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2025.
Via InvestorPlace · August 6, 2024
Why NYSE:STE provides a good dividend, while having solid fundamentals.chartmill.com
Why the dividend investor may take a look at STERIS PLC (NYSESTE).
Via Chartmill · May 9, 2024
What 4 Analyst Ratings Have To Say About Sterisbenzinga.com
Via Benzinga · February 9, 2024
Recap: Steris Q3 Earningsbenzinga.com
Via Benzinga · February 7, 2024
These 10 Large Cap Stocks Shined Brightest Last Week (May 5-May 11, 2024): Are They In Your Portfolio?benzinga.com
Toast, Teva, Vistra, Equinix, Applovin, IFF, Constellation, Emerson, IP, and STERIS were top performers last week. Are they in your portfolio?
Via Benzinga · May 12, 2024
STE Stock Earnings: Steris Beats EPS, Misses Revenue for Q4 2024investorplace.com
STE stock results show that Steris beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2024.
Via InvestorPlace · May 8, 2024
Top Stock Reports For Micron Technology, Anheuser-Busch & Duke Energytalkmarkets.com
Today's Research Daily features new research reports on 16 major stocks, including Micron Technology, Inc. (MU), Anheuser-Busch InBev SA/NV (BUD), and Duke Energy Corporation (DUK).
Via Talk Markets · May 2, 2024
Earnings Scheduled For February 7, 2024benzinga.com
Companies Reporting Before The Bell • Madison Square Garden (NYSEMSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.
Via Benzinga · February 7, 2024
Earnings Outlook For Sterisbenzinga.com
Via Benzinga · February 6, 2024
Steris Exceeds Expectations with Strong Performance, Driving Profits and Rewarding Investorsbenzinga.com
At the end of today, December 21, 2023, Steris (NYSESTE) will distribute a dividend payout of $0.52 per share, translating to an annualized dividend yield of 0.99%. Shareholders who held the stock before the ex-dividend date on November 20, 2023 will benefit from this payout.
Via Benzinga · December 21, 2023
Analyst Expectations for Steris's Futurebenzinga.com
Via Benzinga · December 4, 2023
Recap: Steris Q2 Earningsbenzinga.com
Via Benzinga · November 7, 2023